|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 409 12th Street, SW |
Address2 |
|
City | Washington |
State | DC |
Zip Code | 20024 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 400578740-12
|
||||||||
|
6. House ID# 412490000
|
TYPE OF REPORT | 8. Year | 2021 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Rachel Roberts |
Date | 1/20/2022 8:43:44 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Funding for National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Health Resources and Services Administration (HRSA); Centers for Disease Control and Prevention (CDC); Agency for Healthcare Research and Quality (AHRQ); American Indian/Alaska Native Womens Health (IHS); International Family Planning; Health Disparities (HHS); Safe Motherhood (CDC); Global Maternal and Child Health (USAID); Maternal Mortality and Morbidity (CDC, HRSA); Maternal Therapeutics Research and Regulation (HHS, NIH, FDA); Reproductive Health (general); Womens Health Research (NIH); Gun Violence Research (CDC); Medicaid and Medicare (CMS); Division of Reproductive Health (CDC); Pregnancy Risk Assessment Monitoring System (CDC); National Center on Birth Defects and Developmental Disabilities (CDC); National Center for Environmental Health (CDC); National Center for Health Statistics (CDC); Public Health Surveillance (general); Public Health Data/IT Systems Modernization (CDC); Unique Patient Identifier (HHS); National Health Service Corps (HRSA); Substance Use Disorder Treatment (SAMHSA); Office on Smoking and Health (CDC); Title V Block Grant (HRSA); Title X Family Planning Program (OPA); Teen Pregnancy Prevention Program (OAH); Screening and Treatment for Maternal Depression (HRSA); Endometriosis (NIH, CDC); public health surveillance (CDC); Fibroids (NIH); Pediatric Subspecialty Loan Repayment Program; WIC Breastfeeding Peer Counselor Program (Ag); Newborn Screening (general); Rural Training Track (HRSA); COVID-19 Response (general); Department of Defense Congressionally Directed Medical Research Programs (CDMRP); Teaching Health Center Graduate Medical Education (THCGME) Program; Consumer Assistance Programs (CMS); implementation of P.L. 115-320, Improving Access to Maternity Care Act (Maternity Care Target Areas); H.R.___/S.___, Fiscal Year 2022 Labor, Health and Human Services, Education Appropriations Act
17. House(s) of Congress and Federal agencies Check if None
Centers For Disease Control & Prevention (CDC), Office of Management & Budget (OMB), Natl Institutes of Health (NIH), U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Health & Human Services - Dept of (HHS), Substance Abuse & Mental Health Services Administration (SAMHSA), Food & Drug Administration (FDA), Justice - Dept of (DOJ), Centers For Medicare and Medicaid Services (CMS), Agency for Healthcare Research & Quality (AHRQ), Indian Health Service, U.S. Agency for International Development (USAID), Defense - Dept of (DOD), Education - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Tetlow |
|
|
|
Tatiana |
Calderon |
|
|
|
Drew |
Hatter |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Health Insurance Coverage (general); Health Disparities (general); Breastfeeding (general); Assisted Reproductive Technology (general); Smoking Cessation (general); Substance Use Disorder (general); Gynecologic Cancer (general); Gynecologic Devices (general); Reproductive Health (general); Intimate Partner Violence (general); Gun Violence (general); Immunization (general); Breast Cancer (general); Medical Liability Reform (general); Health IT (general); Patient-Physician Relationship (general); Child Welfare (general); Prematurity (general); Maternal Mortality and Morbidity (general); Graduate Medical Education (general); Contraception (general); Abortion (general); Indian Health (general); Teaching Health Centers Graduate Medical Education (general); Community Health Centers (general); National Health Service Corps (general); Health care workforce (general); Title VII Health Workforce Programs (general); Special Diabetes Program (general); Special Diabetes Program for Indians (general); Sexuality Education (general); Teen Pregnancy Prevention Program (general); Personal Responsibility Education Program (general); Sexually Transmitted Infections (general); Tobacco Cessation (general); Access and Provision of Medication-based Opioid Use Disorder Treatment (HHS); Research in Pregnant and Breastfeeding Women (general); Health Care Reform (general); Title X Family Planning Program (general); Womens Preventive Services (general); Administrative Burden (general); COVID-19 Response (general); Risk Evaluation and Mitigation Strategies (general); Data Collection (general); Health Equity (general); Pregnancy Risk Assessment Monitoring System (CDC); Provider Relief Fund (general); Maternal Mental Health (general); Violence Against Women Act (general); COVID-19 Vaccine (general); H.R. 3755/S. 1975, Womens Health Protection Act; H.R. _/S. _, VACCINES Act; implementation of P.L. 115-344, Preventing Maternal Deaths Act; implementation of P.L. 115-320, Improving Access to Maternity Care Act; H.R. 4387/S.1675, Maternal Health Quality Improvement Act; H.R. 959/ S. 346, the Black Maternal Health Momnibus Act of 2021; implementation of P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020; implementation of P.L. 116-127, the Families First Coronavirus Response Act; implementation of P.L. 116-136, the Coronavirus Aid, Relief, and Economic Security Act; implementation of P.L. 116-139, Paycheck Protection Program and Health Care Enhancement Act; H.R. 3021 the Coronavirus Provider Protection Act; H.R. 1065/S. 1486, the Pregnant Workers Fairness Act; H.R. _/S._, the Maternal Health Pandemic Response Act; H.R.1667/S. 610, Lorna Breen Health Care Provider Protection Act; S, 176, Ensuring Understanding of COVID-19 to Protect Public Health Act; H.R. 736/S. 167, Community Immunity During COVID-19 Act; H.R. 1350/ S.408, Supporting Best Practices for Healthy Moms Act; H.R. 3407/S. 411; MOMMAs Act; H.R. 769/S.1491, Rural MOMS Act; Implementation of P.L. 117-2, the American Rescue Plan Act of 2021; H.R. 2216 /S.1063, the Jeanette Acosta Invest in Womens Health Act; H.R. 2007, Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2021; H.R. 3110/S. 1658, PUMP for Nursing Mothers Act; H.R. 2903/S.1515, CONNECT for Health Act; H.R. 3671/S.1958, Doctors of Community (DOC) Act; H.Res.375, Supporting the goals and ideals of the month of May as Sex Ed For All Month: Equity and Access for All; Implementation of P.L. 114-255, the 21st Century Cures Act; Implementation of the No Surprises Act contained in P.L. 116-260, Consolidated Appropriations Act, 2021; S.Res.172/H.Res.344, a Resolution Declaring Racism a Public Health Crisis; H.R. 666/S. 162, the Anti-Racism in Public Health Act; S. 1234/H.R. 2556, the Maternal CARE Act; S. 1333, the MOMS Act; S. 198/H.R. 1218, the Data Mapping to Save Moms Lives Act; H.R. 1439, Expanded Genetic Screening Act of 2021; S. 1622, the HEALTH for MOM Act of 2021; H.R. 482/S. 350, Newborn Screening Saves Lives Reauthorization Act; H.R. 5/S. 393, Equality Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), Natl Institutes of Health (NIH), Centers For Medicare and Medicaid Services (CMS), Substance Abuse & Mental Health Services Administration (SAMHSA), Office of Management & Budget (OMB), White House Office, Executive Office of the President (EOP), Government Accountability Office (GAO)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Tetlow |
|
|
|
Tatiana |
Calderon |
|
|
|
Lisa |
Satterfield |
|
|
|
Emily |
Eckert |
|
|
|
Drew |
Hatter |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Childrens Health Insurance Program (CHIP); Implementation of P.L. 114-10, Medicare Access and CHIP Reauthorization Act of 2015; Medicaid (general); Medicare (general); Telemedicine coverage and reimbursement (general); Medicare reimbursement (general); Health Care Reform (general); Medicaid DSH Payments (general); Medicaid Fiscal Accountability Regulation (general); Durable Medical Equipment (general); Maternal Mortality and Morbidity (general); COVID-19 Response (general); S.801, Connected MOM Act; H.R. 3345, Helping MOMS Act; Extending Medicaid coverage to 12 months postpartum; Medicare Sequestration (general); S. 748, the Medicare Sequester Relief Act; H.R. 315 the Medicare Sequester COVID Moratorium Act; H.R.2256/S. 834, Resident Physician Shortage Reduction Act; Consumer Assistance Programs (CMS); H.R. 4110, Reducing Hereditary Cancer Act; Implementation of new Graduate Medical Education slots contained in P.L. 116-260, Consolidated Appropriations Act, 2021; H.R. 3173, Improving Seniors Timely Access to Care Act of 2021; H.R. 1025, the Kids Access to Primary Care Act of 2021; S. 1833, the Ensuring Access to Primary Care for Women & Children Act; H.R. 3517/S. 1943, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Tetlow |
|
|
|
Tatiana |
Calderon |
|
|
|
Lisa |
Satterfield |
|
|
|
Emily |
Eckert |
|
|
|
Drew |
Hatter |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
Congressionally Directed Medical Research Programs (CDMRP); Ovarian cancer research (general); Gynecologic cancer (general); Contraception Access (general); Emergency Contraception (general); Military Sexual Trauma (general); Military Womens Health (general); Maternal Mortality and Morbidity (general); Postpartum care (general); Assisted Reproductive Technology (general); Uniformed Services University of the Health Sciences; Military Health System (general); H.R. 2709/S. 1238, Access to Contraception for Women Servicemembers and Dependents Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Defense - Dept of (DOD)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Tetlow |
|
|
|
Tatiana |
Calderon |
|
|
|
Drew |
Hatter |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Womens Health Research (general); Assisted Reproductive Technology (general); Gender based health services (general); Provider scope of practice (general); Military Sexual Trauma (general); Abortion (general); Contraception (general); H.R. 958/S. 796, Protecting Moms Who Served Act; H.R. 239, Equal Access to Contraception for Veterans Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Tetlow |
|
|
|
Tatiana |
Calderon |
|
|
|
Drew |
Hatter |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
Immigration and womens health (general); Health care workforce (general); Abortion (general); Womens health in immigration detention; International medical graduates (general); Informed consent (general); Work Visas (general); H.R. 3149/S. 1660, HEAL for Immigrant Families Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Homeland Security - Dept of (DHS), Justice - Dept of (DOJ), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Tetlow |
|
|
|
Tatiana |
Calderon |
|
|
|
Emily |
Eckert |
|
|
|
Drew |
Hatter |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
Special Supplemental Nutrition Program for Women, Infants, and Children (general)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Agriculture - Dept of (USDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Tetlow |
|
|
|
Tatiana |
Calderon |
|
|
|
Drew |
Hatter |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
Family planning (general); Maternal health (general); abortion (general); H.R. 556/S. 142, Global Health, Empowerment and Rights (HER) Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, U.S. Agency for International Development (USAID), State - Dept of (DOS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Tetlow |
|
|
|
Tatiana |
Calderon |
|
|
|
Drew |
Hatter |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R. 4122, Resident Education Deferred Interest Act (REDI Act)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Education - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Tetlow |
|
|
|
Tatiana |
Calderon |
|
|
|
Drew |
Hatter |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |